Side by side
Compare
Search a ticker or company to build a side-by-side comparison of sourced identity, market snapshot and verified financials. Share prices stay live on this page; deeper reporting stays on each Company File.
Build the set
Choose 2–4 instruments
- ROIV
Quick examples
One instrument selected. Add another to compare.
| Field | ROIV |
|---|---|
| Instrument | |
| Name | Roivant Sciences Ltd. |
| Kind | Stock |
| Exchange | Nasdaq |
| Category | Operating company |
| What it tracks / does | Roivant is a biopharmaceutical company that aims to improve the lives of patients by accelerating the development and commercialization of medicines that matter. |
| Company File | Available |
| Latest verified financials | |
| Reporting period | FDA approval announced August 27, 2026 |
| Revenue | Not available |
| Net income | Not available |
| Diluted EPS | Not available |
| Sources | |
| Primary source | Roivant Sciences Ltd. Form 10-K business description |
| Verified financials | Open 8-K |
| Latest quote | Latest quote |
Broad-market ETFs currently covered: VOO, QQQ, DIA. An ETF share price is not the index it tracks. Valuation, profitability and return rows stay off this table.